Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetic and efficacy of saquinavir mesylate film coated tablet / ritonavir 1500/100 plus tenofovir/emtricitabine 300/200 mg once daily in HIV pretreated patients

Next Previous
Search
Trial Profile

Pharmacokinetic and efficacy of saquinavir mesylate film coated tablet / ritonavir 1500/100 plus tenofovir/emtricitabine 300/200 mg once daily in HIV pretreated patients

Status: Withdrawn prior to enrolment
Phase of Trial: Phase II/III

Latest Information Update: 10 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Saquinavir (Primary) ; Emtricitabine/tenofovir disoproxil fumarate; Ritonavir
  • Indications HIV infections
  • Focus Pharmacokinetics

Most Recent Events

  • 04 Jun 2010 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov record.
  • 14 Mar 2008 The expected completion date for this trial is now 1 Nov 2009, according to ClinicalTrials.gov.
  • 14 Mar 2008 Status changed from initiated to recruiting, as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top